BACE1 and Alzheimer disease: BACE1 has broad biological functions in cells, but in the respect of AD therapy development, scientists are devoted to searching a way of inhibiting its undue cleavage of APP without impacting other substrates that have important physiological functions in vivo (Vassar, 2014).